Skip to main content
. 2015 Nov 8;4(4):94–105. doi: 10.5409/wjcp.v4.i4.94

Table 2.

Risk group stratification for rhabdomyosarcoma according to the International Rhabdomyosarcoma Study

Risk group Histology Pretreatment stage Clinical group
Low (subset 1) Embryonal 1 I, II
1 III (orbit)
2 I, II
Low (subset 2) 1 III (non-orbit)
3 I, II
Intermediate Embryonal 2, 3 III
Alveolar 1, 2, 3 I, II, III
High Any 4 IV